Skip to main content

Latest news

Browse specialties

Breast cancer
Genitourinary cancers
Lung & thoracic cancers

In focus

ROS1 fusion-positive NSCLC
NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC
Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy
ALK fusion-positive NSCLC: International approaches to management
RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC
COVID-19 & cancer

Conferences

SABCS 2022
ESMO 2022
2022 ASCO Annual Meeting

About us

Medicine Matters Oncology
EXTENDED SEARCH
Log in

COVID-19 & cancer

Highlights

10-01-2023 | COVID-19 | News

Antibody testing may identify cancer patients at increased risk of COVID-19 breakthrough infections

A Canadian population-based study has confirmed that people with cancer have an increased risk of breakthrough COVID-19 infection after vaccination, while UK research points to the feasibility of SARS-CoV-2 antibody testing to identify those with the lowest level of vaccine-derived protection.

07-11-2022 | COVID-19 | News

Anticancer therapy tied to worse COVID-19 outcomes in people receiving immunosuppressive agents

People with cancer receiving immunotherapy or other anticancer treatments are at increased risk for adverse COVID-19 outcomes if they are also receiving immunosuppressive therapy, suggests a registry-based cohort study.

11-07-2022 | COVID-19 | News

Cancer screening declined globally during COVID-19 pandemic

A systematic review and meta-analysis has identified global decreases in breast, cervical, and colorectal cancer screening during the early phase of the COVID-19 pandemic.

More on COVID-19 in cancer patients

17-03-2023 | COVID-19 | News

Vaccination ‘protective’ against COVID-19 sequelae in people with cancer

10-01-2023 | COVID-19 | News

Antibody testing may identify cancer patients at increased risk of COVID-19 breakthrough infections

28-11-2022 | COVID-19 | News

Cancer screening uptake fails to return to prepandemic rates

07-11-2022 | COVID-19 | News

Anticancer therapy tied to worse COVID-19 outcomes in people receiving immunosuppressive agents

02-11-2022 | COVID-19 | News

‘Significant’ decrease in serious AE reporting in cancer clinical trials during COVID-19 pandemic

12-08-2022 | WCLC 2022 | Conference coverage | News

Recent thoracic cancer systemic therapy does not increase risk for death after COVID-19

More guidance for oncologists

27-01-2021 | COVID-19 | News

NCCN issues guidance for COVID-19 vaccination in cancer patients

04-09-2020 | COVID-19 | News

COVID-19: Consensus ESMO guidelines on managing cancer patients issued

27-07-2020 | Breast cancer | News

Guidance proposed for managing breast cancer during COVID-19

23-07-2020 | Lung cancer | News

Lung cancer COVID-19 guidance available

21-05-2020 | Comorbidities | News

ASCO releases guidance for resuming oncology practices during COVID-19 outbreak

12-05-2020 | Comorbidities | News

ESMO releases patient guide for cancer care during COVID-19 pandemic

30-04-2020 | Guidelines | News

​​​​​​​ESMO issues guidance for cancer patient management in COVID-19 era

31-03-2020 | Lung cancer | Podcast | Article

COVID-19 and cancer: Changing practices to meet patient needs

25-03-2020 | COVID-19 | Podcast | Article

Managing patients with genitourinary cancers in the time of COVID-19

18-03-2020 | Lung cancer | Podcast | Article

COVID-19 and cancer patient care: A lung cancer specialist’s experience

Stay informed with Medicine Matters

Get the latest developments in breast, lung, & GU cancers delivered straight to your inbox

Sign up for the e-alert today
Image Credits